Vitiligo Therapy with Oral and Topical Phenylalanine with UVA Exposure
Authors:
- N. FrajisNFN. Frajis
- 1 October 1989
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 28 (8) , 545-547
Abstract
The administration of phenylalanine (Phe) combined with UVA exposure was found to be effective in treating vitiligo. Twenty‐one patients with vitiligo were divided in two groups: eleven patients were treated with oral L‐Phe in a dose of 100 mg/kg body weight and with UVA exposure and ten patients were treated with oral L‐Phe in a dose of 100 mg/kg body weight and with UVA exposure. In addition, in the second group, a cream containing 10% L‐Phe was applied to the vitiliginous areas. The best results occurred in the second group. No side effects were found in either group.Keywords
This publication has 6 references indexed in Scilit:
- l-phenylalanine and UVA/sunlight for vitiligoArchives of Dermatological Research, 1985
- Phenylalanine and UVA light for the treatment of vitiligoArchives of Dermatological Research, 1985
- Antibodies to normal human melanocytes in vitiligo.Journal of Experimental Medicine, 1983
- Photochemotherapy of VitiligoArchives of Dermatology, 1976
- Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light systemArchives of Dermatology, 1976
- A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTSPediatrics, 1963